SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-219106
Filing Date
2023-08-23
Accepted
2023-08-23 16:08:09
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 d470666ds3.htm S-3 179577
2 EX-5.1 d470666dex51.htm EX-5.1 6180
3 EX-23.1 d470666dex231.htm EX-23.1 1652
4 EX-FILING FEES d470666dexfilingfees.htm EX-FILING FEES 34188
5 GRAPHIC g470666dsp29.jpg GRAPHIC 10462
6 GRAPHIC g470666g04j69.jpg GRAPHIC 56635
7 GRAPHIC g470666g0822140241584.jpg GRAPHIC 2215
8 GRAPHIC g470666g0822140241785.jpg GRAPHIC 3668
  Complete submission text file 0001193125-23-219106.txt   323938
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274167 | Film No.: 231197647
SIC: 2834 Pharmaceutical Preparations